Morphometric, biochemical and histopathological effects of sofosbuvir (sovaldi) on testes of adult male albino rats

References

• World Health Organization. Global Health Sector Strategies On, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022–2030. Geneva, Switzerland: World Health Organization; 2022.
   Google Scholar
• Sebastiani G, Gkouvatsos K, Pantopoulos K, Chronic hepatitis C and liver fibrosis. World J Gastroenterol. 2014;20(32):11033–11053. doi: 10.3748/wjg.v20.i32.11033
   PubMed Web of Science ®Google Scholar
• Flisiak R, Łucejko M, Mazur W, et al. Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: the real-world HARVEST study. Adv Med Sci. Sep 2017a;62(2):387–392. doi: 10.1016/j.advms.2017.04.004
   PubMed Web of Science ®Google Scholar
• Jacobson IM, McHutchison JG, Dusheiko G, et al. ADVANCE study team. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med. 2011 Jun 23;364(25):2405–16. PMID: 21696307. doi: 10.1056/NEJMoa1012912
   PubMed Web of Science ®Google Scholar
• Poordad F, McCone J Jr, Bacon BR, et al. SPRINT-2 investigators. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med. 2011 Mar 31;364(13):1195–1206. PMID: 21449783; PMCID: PMC3766849. doi: 10.1056/NEJMoa1010494
   PubMed Web of Science ®Google Scholar
• Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA. Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction. J Transl Int Med. 2017;5:8–17. doi: 10.1515/jtim-2017-0007
   PubMed Web of Science ®Google Scholar
• European Medicine Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/sovaldi. 2014
   Google Scholar
• FDA. FDA approves Sovaldi for chronic hepatitis C [Press release]. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm377888.htm. 2013
   Google Scholar
• Mir F, Kahveci AS, Ibdah JA, Tahan V. Sofosbuvir/Velpatasvir regimen promises an effective pangenotypic hepatitis C virus cure. Drug Des Devel Ther. Feb 23, 2017;11:497–502. doi: 10.2147/DDDT.S130945
   PubMed Web of Science ®Google Scholar
• Karageorgopoulos DE, El-Sherif O, Bhagani S, Khoo SH, Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus confection. Curr Opin Infect Dis. 2014;27(1):36–45. doi: 10.1097/QCO.0000000000000034
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir (Harvoni or Sovaldi) in combination with another Direct Acting Antiviral drug. Update Mar 24, 2015.
   Google Scholar
• Farag DBE, El-Baz DA, Salem ZA. Alveolar process changes associated with administration of nucleos(t)ide analogue (sofosbuvir) in rat model. Dent Med Probl. Jan-Mar, 2018;55(1):11–16. PMID: 30152629. doi: 10.17219/dmp/81592
   PubMedGoogle Scholar
• El-Kholy WB, Faried MA, Salama RM, El-Fiky MM, El-Garawani I. Evaluation of testicular cytotoxicity and genotoxicity of sofosbuvir and sofosbuvir - ribavirin in the adult male albino rats. Eur J Anat. 2019;23:393–403.
   Web of Science ®Google Scholar
• Zowail ME, El Kamshishy NA, Khater EH, Evaluation of the role of the silymarin in modulating the cytotoxicity of Sofosbuvir and ribavirin as antiviral drugs in mice bone marrow and sperm. Benha J Appl Sci. 2020;5(6):133–139. doi: 10.21608/bjas.2020.137083
   Google Scholar
• Ebrahim NA, Abdalla HA, Yassin NAE, Maghrabia AE, Morsy AI. Effect of Sofosbuvir on rats’ ovaries and the possible protective role of vitamin E: biochemical and immunohistochemical study. Anat Cell Biol. 2023 Sep 1;56(4):526–537. Epub ahead of print. PMID: 37654017. doi: 10.5115/acb.23.079
   PubMed Web of Science ®Google Scholar
• Gentile I, Borgia F, Buonomo AR, et al. A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir. Curr Med Chem. 2013;20(30):3733–3742. doi: 10.2174/09298673113209990178
   PubMed Web of Science ®Google Scholar
• Paget GC, Barnes JM. Toxicity in Evaluation of the Drug Activities. Laurence DR, Bacharach AL, Pharmacometric. eds. Vol. I 1st ed. London, New York: Academic Press; 1964:1–13.
   Google Scholar
• Ding SP, Li JC, Jin CA, Mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol. 2003;9(3):584–589. doi: 10.3748/wjg.v9.i3.584
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Layton C. The hematoxylins and eosin. In: Suvarna S, Bancroft J Layton C, eds. Bancroft’s Theory and Practice Histology Techniques. 8th ed. New York: Elsevier; 2018a:127–138.
   Google Scholar
• Bancroft JD, Layton C. Connective and other mesenchymal tissues with their stains. In: Suvarna S, Bancroft J Layton C, eds. Bancroft’s Theory and Practice Histology Techniques. 8th ed. New York: Elsevier; 2018b:153–175.
   Google Scholar
• Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. 6th ed. London: Churchill Livingstone; 2008:340–348.
   Google Scholar
• Tipple TE, Rogers LK. Methods for the determination of plasma or tissue glutathione levels. Methods Mol Biol. 2012;889:315–324. PMID:22669674;PMCID:PMC3680121. doi: 10.1007/978-1-61779-867-2_20
   PubMedGoogle Scholar
• Knapp S, Lawner S, Abramowitz W. Statistic Using SPSS: An Integrative Approach. 1st ed. USA: Cambridge University Press; 2014:373–374.
   Google Scholar
• Mould RF. Introductory Medical Statistics. 3rd ed. Bristol, Philadelphia: Institute of Physics Publishing; 1998:18–27.
   Google Scholar
• Mekawy NH, Abdel-Aziz HM, Ibrahem NE, Protective effect of Chrysin on corneal structural alterations induced by sofosbuvir in male albino rats (histological and immunohistochemical study). J Histol Histopathol. 2019;6(1):5. doi: 10.7243/2055-091X-6-5
   Google Scholar
• Ahtiainen M, Toppari J, Poutanen M, Huhta-Niemi I, Indirect Sertoli cell-mediated ablation of germ cells in mice expressing the inhibin-α promoter/herpes simplex virus thymidine kinase transgene. Biol Reprod. 2004;71(5):1545–1550. doi: 10.1095/biolreprod.104.028183
   PubMed Web of Science ®Google Scholar
• Bacon BR, Britton RS. Hepatic injury in chronic iron overload. Role of lipid peroxidation. Chem Biol Interact. 1989;70:183–226. doi: 10.1016/0009-2797(89)90045-8
   PubMed Web of Science ®Google Scholar
• Mohamed AF, Abo-Ouf AM, Arafa MAA, Histological and biochemical studies on effect of Sofosbuvir (Sovaldi) on adult male albino rat kidney. Ultrastruct Pathol. 2021;45(4–5):286–296. doi: 10.1080/01913123.2021.1966148
   PubMed Web of Science ®Google Scholar
• El-Ghazouly DE, Yassien RI. Effect of Sofosbuvir (sovaldi) on the fundic mucosa of adult male albino rats and the possible protective role of Fucoidan: histological, histochemical, and immunohistochemical study. Egypt J Histol. 2022;45:17–25.
   Google Scholar
• Mahran HA, Okdah YA, Zaky AA, Arisha SM, The possible ameliorative role of moringa oleifera seed oil on sofosbuvir‑induced nephrotoxicity in albino rats; histopathological, immunohistochemical and biochemical studies. J Basic Appl Zool. 2022;83(1):16. doi: 10.1186/s41936-022-00281-y
   Google Scholar
• Stedman C, Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential. Therap Adv Gatroenterol. 2014;7(3):131–140. doi: 10.1177/1756283X13515825
   PubMed Web of Science ®Google Scholar
• Feng JY, Xu Y, Barauskas O. Role of mitochondrial RNA polymerase in the toxicity of nucleotide inhibitors of hepatitis C virus. Antimicrob Agents Chemother. 2015;60:806–817. doi: 10.1128/AAC.01922-15
   PubMed Web of Science ®Google Scholar
• El Gharabawy GSH, Abdallah EEA, Kaabo HF, et al. Histological effects of sofosbuvir on the kidney of male albino rats and the possible protective role of vitamin C. Egypt J Hosp Med. 2019;76(1):3335–3354. PubMed. doi: 10.21608/ejhm.2019.36898
   Google Scholar